$JKSM
Jacksam Corp Stock $jksm

$jksm Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000147793223002657 Filed on April 17, 2023

Income Statement

Concept	2023 Q2	2022 Q4	2022
Revenue	$402.6K	$391.2K	$4.128M
YoY Change	-72.56%	-71.41%	-38.83%
Cost Of Revenue	$247.6K	$465.7K	$3.298M
YoY Change	-76.25%	-57.4%	-32.15%
Gross Profit	$155.0K	-$74.50K	$830.5K
YoY Change	-63.52%	-127.06%	-56.02%
Gross Profit Margin	38.5%	-19.04%	20.12%
Selling, General & Admin	$91.08K	$616.8K	$970.3K
YoY Change	-59.68%	10.24%	-22.53%
% of Gross Profit	58.75%		116.83%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00	$100.00	$955.00
YoY Change	-100.0%	-72.97%	-49.09%
% of Gross Profit	0.0%		0.11%
Operating Expenses	$142.4K	$616.8K	$1.931M
YoY Change	-71.51%	10.24%	-23.53%
Operating Profit	$12.67K	-$691.3K	-$1.101M
YoY Change	-116.95%	143.23%	72.79%
Interest Expense	$125.9K	-$506.2K	$422.2K
YoY Change	230.98%	-635.01%	-51.47%
% of Operating Profit	993.37%
Other Income/Expense, Net	-$1.658M		$57.33K
YoY Change	-4258.56%		-90.92%
Pretax Income	-$1.650M	-$1.198M	$2.030M
YoY Change	4627.79%	531.55%	19.81%
Income Tax
% Of Pretax Income
Net Earnings	-$1.645M	-$1.221M	-$1.521M
YoY Change	4614.05%	543.86%	27694.63%
Net Earnings / Revenue	-408.67%	-312.1%	-36.85%
Basic Earnings Per Share	-$0.02		-$0.02
Diluted Earnings Per Share	-$0.02	-$0.02	-$0.02
COMMON SHARES
Basic Shares Outstanding	81.09M shares		79.30M shares
Diluted Shares Outstanding	81.09M shares		79.30M shares

Balance Sheet

Concept	2023 Q2	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$100.0K	$482.9K	$482.9K
YoY Change	-73.24%	40.05%	40.05%
Cash & Equivalents	$98.11K	$482.9K
Short-Term Investments
Other Short-Term Assets	$40.00K	$41.75K	$41.75K
YoY Change	-40.51%	385.47%	385.47%
Inventory	$222.0K	$214.1K	$214.1K
Prepaid Expenses	$37.19K	$41.75K
Receivables	$4.521K	$0.00	$0.00
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$361.8K	$738.8K	$738.8K
YoY Change	-81.24%	-35.27%	-35.27%
LONG-TERM ASSETS
Property, Plant & Equipment	$325.00	$517.00	$78.19K
YoY Change	-57.01%	-64.88%	5219.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$61.57K	$78.19K	$78.20K
YoY Change	-34.56%	5212.09%	5219.73%
TOTAL ASSETS
Total Short-Term Assets	$361.8K	$738.8K	$738.8K
Total Long-Term Assets	$61.57K	$78.19K	$78.20K
Total Assets	$423.4K	$817.0K	$817.0K
YoY Change	-79.07%	-28.51%	-28.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$290.0K	$245.5K	$245.5K
YoY Change	-66.3%	-35.89%	-35.89%
Accrued Expenses	$2.060M	$1.990M	$1.990M
YoY Change	-18.65%	-19.42%	-19.42%
Deferred Revenue
YoY Change
Short-Term Debt	$50.00K	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.070M	$603.1K	$603.1K
YoY Change	81.72%	-23.55%	-23.55%
Total Short-Term Liabilities	$6.733M	$5.038M	$5.038M
YoY Change	42.43%	7.36%	7.36%
LONG-TERM LIABILITIES
Long-Term Debt	$140.0K	$580.1K	$580.1K
YoY Change	-75.57%	-17.72%	-17.72%
Other Long-Term Liabilities	$30.00K	$46.23K	$46.23K
YoY Change	-52.97%
Total Long-Term Liabilities	$170.0K	$626.3K	$626.3K
YoY Change	-73.31%	-11.16%	-11.16%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.733M	$5.038M	$5.038M
Total Long-Term Liabilities	$170.0K	$626.3K	$626.3K
Total Liabilities	$6.900M	$5.664M	$5.664M
YoY Change	28.63%	4.94%	4.94%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.24M	-$12.65M
YoY Change	27.89%	13.67%
Common Stock	$81.09K	$81.09K
YoY Change	0.39%	8.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$6.755M	-$5.119M	-$4.847M
YoY Change
Total Liabilities & Shareholders Equity	$423.4K	$817.0K	$817.0K
YoY Change	-79.07%	-28.51%	-28.51%

Cashflow Statement

Concept	2023 Q2	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$1.645M	-$1.221M	-$1.521M
YoY Change	4614.05%	543.86%	27694.63%
Depreciation, Depletion And Amortization	$0.00	$100.00	$955.00
YoY Change	-100.0%	-72.97%	-49.09%
Cash From Operating Activities	-$90.00K	$184.6K	-$370.7K
YoY Change	-73.09%	-180.94%	-70.04%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change
Cash From Investing Activities	$0.00	$0.00	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-10.00K	-440.0	$508.8K
YoY Change	-89.88%	-98.88%	-53.44%
NET CHANGE
Cash From Operating Activities	-90.00K	184.6K	-$370.7K
Cash From Investing Activities	0.000	0.000	$0.00
Cash From Financing Activities	-10.00K	-440.0	$508.8K
Net Change In Cash	-100.0K	184.1K	$138.1K
YoY Change	-76.92%	-168.87%	-195.4%
FREE CASH FLOW
Cash From Operating Activities	-$90.00K	$184.6K	-$370.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	us-gaap	Revenues Revenues	6749065	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3297955	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	81088	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	74490	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7451916	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6210414	usd
CY2022Q4	jksm	Shares Payable SharesPayable	0	shares
CY2022Q4	jksm	Shares Payable Consisting Common Shares SharesPayableConsistingCommonShares	0	usd
CY2021Q4	jksm	Shares Payable Consisting Common Shares SharesPayableConsistingCommonShares	331600	usd
CY2022	us-gaap	Revenues Revenues	4128456	usd
CY2022	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	18066667	shares
CY2022	us-gaap	Weighted Average Number Of Shares Contingently Issuable WeightedAverageNumberOfSharesContingentlyIssuable	2777778	shares
CY2022Q3	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	18066667	shares
CY2022	jksm	Aggregate Number Beginning AggregateNumberBeginning	11189056	shares
CY2022	jksm	Aggregate Exercise Price Beginning AggregateExercisePriceBeginning	2646044	usd
CY2022	jksm	Weighted Average Exercise Price Beginning WeightedAverageExercisePriceBeginning	0.24
CY2021	jksm	Shares Remaining To Be Issued SharesRemainingToBeIssued	2222221	shares
CY2022	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	180000	usd
CY2021	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	120000	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	192500	usd
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0000860543
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000000	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	74490147	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81088719	shares
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	14279965	shares
CY2021	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	11189056	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2469136	shares
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	165000	usd
CY2021Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	13750	usd
CY2021	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	61133	usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	033-33263
CY2022	dei	Entity Registrant Name EntityRegistrantName	JACKSAM CORPORATION
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3566284
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	3100 Airway Avenue Suite 138
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Costa Mesa
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92626
CY2022	dei	City Area Code CityAreaCode	800
CY2022	dei	Local Phone Number LocalPhoneNumber	605-3580
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2022	dei	Trading Symbol TradingSymbol	JKSM
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	2420000	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	81088719	shares
CY2022	dei	Auditor Name AuditorName	M&K CPAS, PLLC
CY2022	dei	Auditor Firm AuditorFirmId	2738
CY2022	dei	Auditor Location AuditorLocation	Houston, Texas
CY2022Q4	jksm	Right Of Use Liability Operating Lease Current Portion RightOfUseLiabilityOperatingLeaseCurrentPortion	34007	usd
CY2021Q4	jksm	Right Of Use Liability Operating Lease Current Portion RightOfUseLiabilityOperatingLeaseCurrentPortion	0	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	491913	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	325808	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1642269	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2264390	usd
CY2022Q4	jksm	Subscription Payable SubscriptionPayable	499999	usd
CY2021Q4	jksm	Subscription Payable SubscriptionPayable	499999	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5037817	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4692607	usd
CY2022Q4	jksm	Notes Payable Net Of Current Portion NotesPayableNetOfCurrentPortion	580105	usd
CY2021Q4	jksm	Notes Payable Net Of Current Portion NotesPayableNetOfCurrentPortion	705038	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	46233	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5664155	usd
CY2021Q4	us-gaap	Liabilities Liabilities	5397645	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	272022	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	259422	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81088719	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	74490147	shares
CY2021Q4	jksm	Shares Payable SharesPayable	2222223	shares
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4860656	usd
CY2022	us-gaap	Gross Profit GrossProfit	830501	usd
CY2021	us-gaap	Gross Profit GrossProfit	1888409	usd
CY2022	us-gaap	Salaries And Wages SalariesAndWages	961069	usd
CY2021	us-gaap	Salaries And Wages SalariesAndWages	1273064	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	970267	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1252450	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1931336	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	2525514	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1100835	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-637105	usd
CY2022	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	1515	usd
CY2021	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	1400011	usd
CY2022	us-gaap	Interest Expense InterestExpense	422158	usd
CY2021	us-gaap	Interest Expense InterestExpense	869902	usd
CY2022	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	usd
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	58642	usd
CY2022	jksm	Gain On Settlement Of Notes Payable GainOnSettlementOfNotesPayable	0	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	57328	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	631631	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1521478	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-5474	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	92600	usd
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	7422	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1614078	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12896	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	79302098	shares
CY2021	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	72126152	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79302098	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77495288	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-5705452	usd
CY2021	jksm	Issuance Of Series A Preferred Stock Net Of Fees Amount IssuanceOfSeriesAPreferredStockNetOfFeesAmount	0	usd
CY2021	jksm	Common Stock Issued For Debt Conversion Amount CommonStockIssuedForDebtConversionAmount	614198	usd
CY2021	jksm	Common Stock Issued For Deferred Finance Cost Amount CommonStockIssuedForDeferredFinanceCostAmount	172744	usd
CY2021	jksm	Sale Of Common Stock Units Amount SaleOfCommonStockUnitsAmount	187800	usd
CY2021	jksm	Common Stock And Warrants Issued For Settlement Of Notes Payable Amount CommonStockAndWarrantsIssuedForSettlementOfNotesPayableAmount	141118	usd
CY2021	jksm	Common Stock Issued For Services Amount CommonStockIssuedForServicesAmount	15227	usd
CY2021	jksm	Exercise Of Warrants Amount ExerciseOfWarrantsAmount	0	usd
CY2021	jksm	Extinguishment Of Derivative Liability Due To Conversion ExtinguishmentOfDerivativeLiabilityDueToConversion	72958	usd
CY2021	jksm	Shares Returned Under Share Lending Arrangement Amount SharesReturnedUnderShareLendingArrangementAmount	0	usd
CY2021	jksm	Dividends On Series A Preferred Stock Amount DividendsOnSeriesAPreferredStockAmount	-7422	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-5474	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4514303	usd
CY2022	jksm	Issuance Of Series B Preferred Stock Net Of Fees Amount IssuanceOfSeriesBPreferredStockNetOfFeesAmount	890000	usd
CY2022	jksm	Common Stock Issued For Share Payable Amount CommonStockIssuedForSharePayableAmount	0	usd
CY2022	jksm	Common Stock And Warrants Issued In Connection With Preferred Stock Amount CommonStockAndWarrantsIssuedInConnectionWithPreferredStockAmount	0	usd
CY2022	jksm	Common Stock Issued For Services Amount CommonStockIssuedForServicesAmount	119200	usd
CY2022	jksm	Dividends On Series A And B Preferred Stock DividendsOnSeriesAAndBPreferredStock	-92600	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1521478	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-5119181	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1521478	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-5474	usd
CY2022	us-gaap	Depreciation Depreciation	955	usd
CY2021	us-gaap	Depreciation Depreciation	1876	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	76978	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	15227	usd
CY2022	us-gaap	Interest And Debt Expense InterestAndDebtExpense	190659	usd
CY2021	us-gaap	Interest And Debt Expense InterestAndDebtExpense	0	usd
CY2022	jksm	Gain On Settlement Of Notes Payable GainOnSettlementOfNotesPayable	0	usd
CY2021	jksm	Gain On Settlement Of Notes Payable GainOnSettlementOfNotesPayable	-160164	usd
CY2022	jksm	Loss On Conversion Of Notes Payable LossOnConversionOfNotesPayable	0	usd
CY2021	jksm	Loss On Conversion Of Notes Payable LossOnConversionOfNotesPayable	58642	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	70485	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	730371	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	28145	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	usd
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	167620	usd
CY2021	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
CY2022	jksm	Derivative Gain Loss DerivativeGainLoss	-1515	usd
CY2021	jksm	Derivative Gain Loss DerivativeGainLoss	-1400011	usd
CY2021	us-gaap	Impairment Of Investments ImpairmentOfInvestments	18000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	400510	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-298334	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-17431	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-25289	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-33151	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-139859	usd
CY2022	jksm	Increase Decrease Of Right Of Use Liabilities IncreaseDecreaseOfRightOfUseLiabilities	-25582	usd
CY2021	jksm	Increase Decrease Of Right Of Use Liabilities IncreaseDecreaseOfRightOfUseLiabilities	0	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-40591	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	540646	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	333742	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-852695	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-370654	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1237345	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	570000	usd
CY2022	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-300000	usd
CY2021	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-905503	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5000	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	327385	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1024024	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	408634	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	92925	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	250000	usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	890000	usd
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	252000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	508751	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1092596	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	138097	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-144749	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	344811	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	489560	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	482908	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	344811	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	19699	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	118732	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	105822	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022	jksm	Common Stock Issued To Settle Convertible Notes Payable CommonStockIssuedToSettleConvertibleNotesPayable	0	usd
CY2021	jksm	Common Stock Issued To Settle Convertible Notes Payable CommonStockIssuedToSettleConvertibleNotesPayable	614198	usd
CY2022	jksm	Derivative Liability Recognized At Issuance Of Warrants And Conversion Option DerivativeLiabilityRecognizedAtIssuanceOfWarrantsAndConversionOption	0	usd
CY2021	jksm	Derivative Liability Recognized At Issuance Of Warrants And Conversion Option DerivativeLiabilityRecognizedAtIssuanceOfWarrantsAndConversionOption	493670	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Restricted Stock Expense RestrictedStockExpense	2670	usd
CY2021	us-gaap	Restricted Stock Expense RestrictedStockExpense	172744	usd
CY2022	jksm	Common Stock Issued To Settle Share Payable CommonStockIssuedToSettleSharePayable	331600	shares
CY2022	jksm	Lossonadditionalshares Issued In Connection With Common Stock Units LossonadditionalsharesIssuedInConnectionWithCommonStockUnits	42222	usd
CY2022	jksm	Preferred Stock Dividends Non Cash PreferredStockDividendsNonCash	92600	usd
CY2021	jksm	Preferred Stock Dividends Non Cash PreferredStockDividendsNonCash	7422	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20644	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20644	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20127	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19172	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements is in conformity with U.S. GAAP and requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Such estimates and assumptions impact both assets and liabilities, including but not limited to net realizable value of accounts receivable and inventory, estimated useful lives and potential impairment of property and equipment, estimate of fair value of share-based payments and derivative liabilities, estimates of fair value of warrants issued and recorded as debt discount and estimates of the probability and potential magnitude of contingent liabilities. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future nonconforming events. Accordingly, actual results could differ significantly from estimates.</p>
CY2022	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	264659	usd
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	74000	usd
CY2022	jksm	Bad Debts Expense BadDebtsExpense	190659	usd
CY2021	jksm	Bad Debts Expense BadDebtsExpense	0	usd
CY2022	jksm	Inventory Allowance InventoryAllowance	18800	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	1127634	usd
CY2022	jksm	Machine Sales MachineSales	2668102	usd
CY2021	jksm	Machine Sales MachineSales	5218158	usd
CY2022	jksm	Non Machine Sales NonMachineSales	1460354	usd
CY2021	jksm	Non Machine Sales NonMachineSales	1530907	usd
CY2022	us-gaap	Revenues Revenues	4128456	usd
CY2021	us-gaap	Revenues Revenues	6749065	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	517	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1472	usd
CY2022	us-gaap	Depreciation Depreciation	955	usd
CY2021	us-gaap	Depreciation Depreciation	1876	usd
CY2022	jksm	Summary Of Effect Of Potential Dilutive Issuances SummaryOfEffectOfPotentialDilutiveIssuances	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Year Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net income (loss) attributable to common stockholders</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,614,078</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(12,896</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Preferred stock dividends</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">92,600</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">7,422</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Derivative gain</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,515</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">) </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,400,011</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Interest expense associated with convertible debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">98,265</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">846,750</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net income (loss) for dilutive calculation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(1,424,728</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(558,765</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Weighted average shares outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">79,302,098</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">72,126,152</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dilutive effect of preferred stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dilutive effect of convertible debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dilutive effect of common stock warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Weighted average shares outstanding for diluted net income (loss) per share</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">79,302,098</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">72,126,152</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-1614078	usd
CY2021	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-12896	usd
CY2022	jksm	Dividends Preferred Stock1 DividendsPreferredStock1	92600	usd
CY2021	jksm	Dividends Preferred Stock1 DividendsPreferredStock1	7422	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1515	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1400011	usd
CY2022	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	98265	usd
CY2021	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	846750	usd
CY2022	jksm	Net Income Loss For Dilutive Calculation NetIncomeLossForDilutiveCalculation	-1424728	usd
CY2021	jksm	Net Income Loss For Dilutive Calculation NetIncomeLossForDilutiveCalculation	-558765	usd
CY2022	jksm	Weighted Average Shares Outstanding WeightedAverageSharesOutstanding	79302098	usd
CY2021	jksm	Weighted Average Shares Outstanding WeightedAverageSharesOutstanding	72126152	usd
CY2021	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	0	usd
CY2022	jksm	Dilutive Effect Of Convertible Debt DilutiveEffectOfConvertibleDebt	0	usd
CY2021	jksm	Dilutive Effect Of Convertible Debt DilutiveEffectOfConvertibleDebt	0	usd
CY2022	jksm	Dilutive Effect Of Common Stock Warrants DilutiveEffectOfCommonStockWarrants	0	usd
CY2021	jksm	Dilutive Effect Of Common Stock Warrants DilutiveEffectOfCommonStockWarrants	0	usd
CY2022	jksm	Weighted Average Shares Outstanding For Diluted Net Income Loss Per Share WeightedAverageSharesOutstandingForDilutedNetIncomeLossPerShare	79302098	usd
CY2021	jksm	Weighted Average Shares Outstanding For Diluted Net Income Loss Per Share WeightedAverageSharesOutstandingForDilutedNetIncomeLossPerShare	72126152	usd
CY2022	jksm	Effect Of Common Stock Warrants EffectOfCommonStockWarrants	14279965	usd
CY2022	jksm	Effect Of Convertible Preferred Debt EffectOfConvertiblePreferredDebt	75585790	usd
CY2022	jksm	Effect Of Preferred Stock EffectOfPreferredStock	18066667	usd
CY2021	jksm	Effect Of Preferred Stock EffectOfPreferredStock	1400000	usd
CY2021	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	3969136	shares
CY2021	jksm	Effect Of Common Stock Warrants EffectOfCommonStockWarrants	11189056	usd
CY2021	jksm	Unissued Shares UnissuedShares	2777778	shares
CY2022	jksm	Unissued Shares UnissuedShares	2222221	shares
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	169874	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	38024	usd
CY2022	jksm	Aggregate Exercise Price Exercised1 AggregateExercisePriceExercised1	-909091	usd
CY2022	jksm	Aggregate Exercise Price Exercised AggregateExercisePriceExercised	500000	usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.45
CY2022	jksm	Less Forfeited And Cancelled LessForfeitedAndCancelled	0	usd
CY2022	jksm	Aggregate Exercise Price Forfeited And Cancelled AggregateExercisePriceForfeitedAndCancelled	0	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	58739	usd
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	28066	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	558879	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	587775	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	832872	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	914121	usd
CY2022Q4	jksm	Debt Instrument Unamortized Discount1 DebtInstrumentUnamortizedDiscount1	94095	usd
CY2021Q4	jksm	Debt Instrument Unamortized Discount1 DebtInstrumentUnamortizedDiscount1	121309	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	158672	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	87774	usd
CY2021Q4	jksm	Notes Payable Net Of Current Portion NotesPayableNetOfCurrentPortion	705038	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	27215	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	6935	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	444444	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1048524	usd
CY2022Q4	jksm	Debt Discount And Deferred Finance Costs On Short Term Convertible Notes DebtDiscountAndDeferredFinanceCostsOnShortTermConvertibleNotes	0	usd
CY2021Q4	jksm	Debt Discount And Deferred Finance Costs On Short Term Convertible Notes DebtDiscountAndDeferredFinanceCostsOnShortTermConvertibleNotes	-239282	usd
CY2022Q4	jksm	Current Convertible Notes Payable Net Of Discount CurrentConvertibleNotesPayableNetOfDiscount	444444	usd
CY2021Q4	jksm	Current Convertible Notes Payable Net Of Discount CurrentConvertibleNotesPayableNetOfDiscount	809242	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	0	usd
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	0	usd
CY2022	jksm	Convertible Notes Payable1 ConvertibleNotesPayable1	444444	usd
CY2022	jksm	Total Gain TotalGain	1515	usd
CY2021	jksm	Total Gain TotalGain	1400011	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	jksm	Common Stock Designated CommonStockDesignated	200000000	shares
CY2021Q4	jksm	Preferred Stock Designated PreferredStockDesignated	30000000	shares
CY2021Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.18
CY2021Q4	us-gaap	Share Price SharePrice	0.18
CY2021Q4	jksm	Stock Exercise Price StockExercisePrice	0.27
CY2022	jksm	Shares Remaining To Be Issued SharesRemainingToBeIssued	2222223	shares
CY2022Q4	jksm	Subscriptions Payable Liability Balance SubscriptionsPayableLiabilityBalance	499999	usd
CY2022Q4	jksm	Common Stock Share Issued CommonStockShareIssued	2670034	shares
CY2022	jksm	Fair Value Of Common Stock FairValueOfCommonStock	139800	usd
CY2021	jksm	Aggregate Number Beginning AggregateNumberBeginning	9378056	shares
CY2021	jksm	Aggregate Exercise Price Beginning AggregateExercisePriceBeginning	1921200	usd
CY2021	jksm	Weighted Average Exercise Price Beginning WeightedAverageExercisePriceBeginning	0.20
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2578045	shares
CY2021	jksm	Aggregate Exercise Price Granted AggregateExercisePriceGranted	562343	usd
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.41
CY2021	jksm	Aggregate Exercise Price Exercised1 AggregateExercisePriceExercised1	-767045	usd
CY2021	jksm	Aggregate Exercise Price Exercised AggregateExercisePriceExercised	337500	usd
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.44
CY2021	jksm	Less Forfeited And Cancelled LessForfeitedAndCancelled	0	usd
CY2021	jksm	Aggregate Exercise Price Forfeited And Cancelled AggregateExercisePriceForfeitedAndCancelled	0	usd
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2021	jksm	Aggregate Number Ending AggregateNumberEnding	11189056	shares
CY2021	jksm	Aggregate Exercise Price Ending AggregateExercisePriceEnding	2646044	usd
CY2021	jksm	Weighted Average Exercise Price Ending WeightedAverageExercisePriceEnding	0.24
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	4000000	shares
CY2022	jksm	Aggregate Exercise Price Granted AggregateExercisePriceGranted	800000	usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.20
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2022	jksm	Aggregate Number Ending AggregateNumberEnding	14279965	shares
CY2022	jksm	Aggregate Exercise Price Ending AggregateExercisePriceEnding	2946044	usd
CY2022	jksm	Weighted Average Exercise Price Ending WeightedAverageExercisePriceEnding	0.21
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P2Y3D
CY2022	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	3267	usd
CY2022	jksm	Lease Payments Increased Percentage LeasePaymentsIncreasedPercentage	0.04	pure
CY2022Q4	jksm	Right Of Use Asset And Lease Liability RightOfUseAssetAndLeaseLiability	105822	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	36866	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	0	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	24220	usd
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	111043	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	0	usd
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	0	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	0	usd
CY2021	us-gaap	Sublease Income SubleaseIncome	0	usd
CY2022	us-gaap	Lease Cost LeaseCost	61086	usd
CY2021	us-gaap	Lease Cost LeaseCost	111043	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	77677	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	34007	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	46233	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	80240	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	0	usd
CY2022Q4	jksm	Incremental Borrowing Rate Percentage IncrementalBorrowingRatePercentage	0.10	pure
CY2022	jksm	Lease Remaining Terms LeaseRemainingTerms	P2Y5M1D
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	40511	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	42123	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	7065	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2022Q4	jksm	Lessee Operating Lease Liability Payments Due After Year Six LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix	0	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	89699	usd
CY2022Q4	jksm	Less Interest Lessee Operating Lease Liability LessInterestLesseeOperatingLeaseLiability	9459	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	80240	usd
CY2022Q4	jksm	Accrued Liabilities Other AccruedLiabilitiesOther	1642269	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2029845	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1694212	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1900	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1900	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2031745	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1696112	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2031537	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1695904	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	208	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	208	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0659	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.5850	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	-0.0581	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	-2.407	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2207	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	2.782	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Other EffectiveIncomeTaxRateReconciliationTaxSettlementsOther	0.0029	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Other EffectiveIncomeTaxRateReconciliationTaxSettlementsOther	0.0000	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.0000	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.0000	pure
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	631000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	7120000	usd

Files In Submission

Name	View Source	Status
0001477932-23-002657-index-headers.html	Edgar Link	pending
0001477932-23-002657-index.html	Edgar Link	pending
0001477932-23-002657.txt	Edgar Link	pending
0001477932-23-002657-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
jksm-20221231.xsd	Edgar Link	pending
jksm_10k.htm	Edgar Link	pending
jksm_ex311.htm	Edgar Link	pending
jksm_ex321.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
jksm-20221231_cal.xml	Edgar Link	unprocessable
jksm-20221231_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
jksm-20221231_lab.xml	Edgar Link	unprocessable
jksm-20221231_pre.xml	Edgar Link	unprocessable
jksm_10k_htm.xml	Edgar Link	completed
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JKSM
Jacksam Corp Stock $jksm

2023 Q2 Form 10-K Financial Statement

#000147793223002657 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JKSM Jacksam Corp Stock $jksm

2023 Q2 Form 10-K Financial Statement

#000147793223002657 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JKSM
Jacksam Corp Stock $jksm